532305 (2)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE lists 51,00,000 new equity shares of Ind-Swift Laboratories Ltd. issued on preferential basis to promoters via conversion of warrants, … | |||||||||||||||
BSE lists 51,00,000 new equity shares of Ind-Swift Laboratories Ltd. issued on preferential basis to promoters via conversion of warrants, effective April 17, 2026.
| |||||||||||||||
BSE received clarifications from 60 listed companies regarding significant price/volume movement observed in their scrips. Replies are … | |||||||||||||||
BSE received clarifications from 60 listed companies regarding significant price/volume movement observed in their scrips. Replies are awaited from a few additional companies.
| |||||||||||||||